Skip to main content
. 2008 Oct 17;19(3):731–744. doi: 10.1007/s00330-008-1194-4

Table 5.

FDG-PET/CT parameters

Study and year Time of fasting before FDG administration (h) FDG dose (MBq) Time interval between FDG administration and data acquisition (min) No. of CT detector rows Reconstructed slice width (mm) Intravenous CT contrast Oral CT contrast Area of body scanned
Fencl et al. [12], 2007 ≥6 350–450 60–90 2 4.0 Yes and no Yes From the skull base to below the groin
Nassenstein et al. [13], 2007 ≥4 350 60 2 -3.0 (head and neck) Yes Yes From the head to the upper thigh
-5.0 (chest and abdomen)
Fleming et al. [14], 2007 NR 555 75 16 NR NR NR From the top of the head to midthigh
Bruna et al. [15], 2007 ≥6 5.5/kg (max. 550) 60 NR NR NR NR From the top of the head to midthigh
Wartski et al. [16], 2007 ≥6 4–5/kg 60 NR 5.0 No No From the skull to the midthigh
Ambrosini et al. [18], 2006 6 370 60–90 NR NR NR NR “Whole-body”
Fakhry et al. [20] 2006 ≥6 260–330 60 NR NR NR NR From the skull base to the thighs
Pelosi et al. [22], 2006 ≥6 222–370 60 NR NR NR NR From neck to pelvis or from skull to feet
Nanni et al. [26], 2005 ≥6 370 60–90 NR NR NR NR “Total body scan”
Freudenberg et al. [27], 2005 ≥10 360 60 2 -3.0 (head and neck) -No (head and neck -No (head and neck) Head, neck, thorax, abdomen and pelvis
-5.0 (from thorax to pelvis) -Yes (thorax to pelvis) -Yes (thorax to pelvis)
Gutzeit et al. [29], 2005 ≥4 350 60 2 5.0 Yes Yes Head, neck, thorax, abdomen and pelvis

CT: computed tomography

FDG: 18F-fluoro-2-deoxyglucose

NR: not reported